Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1067588/000119312504173917/dex991.htm
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1067588/000119312504173917/dex991.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aclara Biosciences Inc.
Aclara Biosciences Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2004 10-K Annual Report includes:
CIK: 1067588Events:
Form Type: 8-K Corporate News
Accession Number: 0001193125-04-173917
Submitted to the SEC: Tue Oct 19 2004 8:07:50 PM EST
Accepted by the SEC: Wed Oct 20 2004
Period: Monday, October 18, 2004
Industry: Measuring And Controlling Devices